Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mesoblast Ltd (NASDAQ:MESO)

4.37
Delayed Data
As of 1:54pm ET
 +0.1006 / +2.36%
Today’s Change
3.50
Today|||52-Week Range
13.00
-31.28%
Year-to-Date
No recent news for Mesoblast Ltd.

Today’s Trading

Previous close4.27
Today’s open4.30
Day’s range4.29 - 4.46
Volume11,289
Average volume (3 months)37,712
Market cap$322.7M
Dividend yield--
Data as of 1:54pm ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-1,324.26%
Earnings growth (next 5 years)-0.34%
Revenue growth (last year)+143.13%
P/E ratio--
Price/Sales6.89
Price/Book0.61

Competitors

 Today’s
change
Today’s
% change
IVCInvacare Corp-0.02-0.18%
CFMSConforMIS Inc-0.08-0.83%
RTIXRTI Surgical Inc+0.03+0.98%
SIENSientra Inc+0.25+2.98%
Data as of 3:41pm ET, 09/28/2016

Financials

Next reporting dateDecember 14, 2016
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$41.5M
Annual profit (last year)-$4.1M
Net profit margin-9.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, MD &
Executive Director
Silviu Itescu
Chief Financial Officer
Paul Hodgkinson
Corporate headquarters
Melbourne, Victoria (vic)

Forecasts

Search for Jobs